Recalls / Firms / Sciegen Pharmaceuticals Inc
Sciegen Pharmaceuticals Inc
7 FDA drug recalls on record.
| Date | Class | Drug | Status |
|---|---|---|---|
| 2023-02-17 | Class III | Gabapentin | Terminated |
| 2018-10-29 | Class II | Westminister Irbesartan Tablets, USP, 150 mg, (a) 30-count bottle (NDC 69367-120-01), (b) | Terminated |
| 2018-10-29 | Class II | Westminister Irbesartan Tablets, USP, 75 mg (a) 30-count bottle (NDC 69367-119-01), (b) 90 | Terminated |
| 2018-10-29 | Class II | GSMS Irbesartan Tablets, USP, 150 mg, (a) 30-count bottle (NDC 60429-641-30), (b) 90-count | Terminated |
| 2018-10-29 | Class II | GSMS Irbesartan Tablets, USP, 300 mg,(a) 30-count bottle (NDC 60429-642-30), (b) 90-count | Terminated |
| 2018-10-29 | Class II | Westminister Irbesartan Tablets, USP, 300mg, Rx Only,(a) 30-count bottle (NDC 69367-121-01 | Terminated |
| 2018-10-29 | Class II | GSMS Irbesartan Tablets, USP, 75 mg, 30-count bottle, Rx Only, Manufactured by ScieGen Pha | Terminated |